Investors

Investors

Company Profile

Arena is a biopharmaceutical company focused on discovering and developing novel, small molecule drugs. We are currently directing our activities and resources primarily on:

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

Events & Presentations
Annual Report and Proxy Statement
Date Title and Summary
Toggle Summary Arena Pharmaceuticals to Report First Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, April 18, 2007
Arena Pharmaceuticals to Report First Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, April 18, 2007 SAN DIEGO, April 11, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will report first
Toggle Summary Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
- Analyses Estimate Humans Concentrate Lorcaserin in the Brain to a Much Lower Extent than Rats -<br>- Data to be Included in Response to Lorcaserin CRL -